Co-Antibody Therapy Effective in Highly Refractory IBD
(MedPage Today) -- The co-antibody therapy JNJ-4804 -- a fixed-dose combination of guselkumab (Tremfya) and golimumab (Simponi) -- showed clinically ...
Tag: CoAntibody
(MedPage Today) -- The co-antibody therapy JNJ-4804 -- a fixed-dose combination of guselkumab (Tremfya) and golimumab (Simponi) -- showed clinically ...